BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Biotech Bay

  Cytokinetics Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4) - Nov 01, 2021

  Cytokinetics, Incorporated announced that on October 29, 2021 it granted stock options to purchase an aggregate of 68,550 shares of common stock to 8 new employees, whose employment commenced in October 2021, as a material inducement to their employment.

  November 1, 2021

   · 

  3 min read
• Biotech Bay

  Berkeley Lights to Present on Cell Line Development of Complex Molecules and Accelerating Antibody Discovery Against Difficult Targets at 13th Annual PEGS Europe

  Berkeley Lights, Inc., a leader in digital cell biology, announced its participation at the 13th Annual PEGS Europe: Protein & Antibody Engineering Summit, being held virtually and in person from November 2-4, 2021, in Barcelona, Spain.

  November 1, 2021

   · 

  4 min read
• Biotech Beach

  Reneo Pharmaceuticals to Participate at Upcoming Investor Conferences - Nov 01, 2021

  Reneo Pharmaceuticals, Inc., a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare, genetic, mitochondrial diseases, announced that it will be participating in the following investors conferences during the month of November.

  November 1, 2021

   · 

  1 min read
• Business

  Semler Reports Third Quarter and Year-to-Date 2021 Financial Results

  Semler Scientific, Inc., a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, reported financial results for the three and nine months ended September 30, 2021.

  November 1, 2021

   · 

  9 min read
• Genetown

  Compass Therapeutics Announces Pricing of Approximately $125 Million Public Offering of Common Stock and Uplisting to Nasdaq Capital Market

  Compass Therapeutics, Inc., a clinical-stage biopharmaceutical company developing proprietary antibody-based therapeutics to treat cancer, announced that it has priced an underwritten public offering to sell 35,715,000 shares of common stock at a public offering price of $3.50 per share.

  November 1, 2021

   · 

  5 min read
• Genetown

  uniQure to Participate in Upcoming Industry Conferences in November

  uniQure N.V. today announced its participation in the following upcoming investor and scientific conferences: The 28th Annual Meeting of the Huntington Study Group (Virtual), November 4 - 6, 2021

  November 1, 2021

   · 

  2 min read